Both caloric restriction and intermittent fasting extend lifespan in model organisms, but they do so through overlapping but distinct mechanisms. Here is what the evidence says for humans.
Two of the most studied dietary strategies for extending lifespan are caloric restriction (CR) and intermittent fasting (IF). Both have produced dramatic results in animal models. Both activate overlapping longevity pathways. And both have enthusiastic human proponents. But the question of which is more effective — and for whom — is considerably more nuanced than popular accounts suggest.
The importance of getting this right goes beyond academic interest. Dietary interventions are among the most universally accessible longevity tools available — they require no prescription, no expensive equipment, and are applicable regardless of age or health status. Understanding what the evidence actually shows, rather than what popular books and podcasts claim, is essential for making informed decisions about how to eat for a longer, healthier life.
Caloric restriction — consuming approximately 20-40% fewer calories than ad libitum intake while maintaining adequate nutrition — is the most robustly documented longevity intervention in laboratory organisms. The evidence is extraordinary in its breadth and consistency:
This convergence across phylogenetically distant species strongly suggests CR is targeting deeply conserved biological mechanisms rather than species-specific quirks. Few interventions in all of biology have been reproduced in so many organisms with such consistent results.
The mechanisms by which CR extends lifespan are now well-characterised at the molecular level. CR downregulates mTOR (mechanistic target of rapamycin) — the cellular growth and anabolism signalling pathway whose inhibition appears to be one of the most conserved and powerful longevity interventions known. Lower mTOR activity triggers a shift from growth and replication toward maintenance, repair, and stress resistance. CR upregulates AMPK (AMP-activated protein kinase), which improves mitochondrial function, promotes autophagy, and increases fatty acid oxidation. CR reduces circulating IGF-1, which is associated with accelerated aging at chronically high levels — probably because high IGF-1 keeps cells in growth mode when they should be in maintenance mode. And CR reliably induces autophagy — the cellular clean-up process that removes damaged proteins and organelles and is increasingly recognised as central to healthy aging.
The most rigorous human evidence for CR comes from the CALERIE (Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy) trial. In phase 2, the most definitive version, 218 healthy non-obese adults aged 21-50 were randomised to either 25% caloric restriction or a control group for two years. This was an unusually well-designed dietary intervention trial — randomised, controlled, with multiple sites, intensive dietary counselling, and biomarker monitoring. Actual achieved CR was approximately 12%, about half the target, demonstrating the difficulty of sustained caloric restriction in a real-world setting.
The results were nonetheless impressive:
In 2023, a follow-up analysis published in Nature Aging (Waziry et al.) provided the most direct evidence yet that CR slows biological aging in humans. CALERIE participants showed slower epigenetic aging — their DNA methylation biological age clocks, which track molecular patterns of aging with high accuracy, ran approximately 2-3% slower than those of control group participants after two years. This is modest in absolute terms but meaningful directionally — it is the first randomised evidence in humans that a dietary intervention changes the rate at which the molecular machinery of aging advances.
The practical challenge of CR, illustrated vividly by CALERIE participants achieving only half their target restriction, is adherence. A 25% reduction in calories is extremely difficult to maintain indefinitely in environments saturated with calorie-dense, highly palatable food. Even participants receiving intensive dietary counselling, group support, and regular monitoring could not consistently achieve their caloric reduction targets. This adherence challenge is a central consideration when comparing CR to intermittent fasting approaches.
Intermittent fasting encompasses several distinct approaches that differ in their mechanisms, practicality, and evidence base:
IF works through a combination of factors: caloric deficit (when total weekly intake is reduced by eating in a compressed window or with restricted days), and fasting-specific metabolic effects that occur independently of calorie balance. Even without net caloric restriction, fasting periods activate autophagy (AMPK rises, mTOR falls), trigger metabolic switching (the shift from glucose to fatty acid and ketone oxidation that activates multiple beneficial transcription factors), and reduce circulating growth factors including insulin and IGF-1.
Circadian biology adds another dimension. Emerging evidence suggests that the timing of food intake relative to the light-dark cycle matters independently of total calories. Eating within the daylight hours (a pattern called early time-restricted eating, or eTRE) activates metabolic pathways that are less active when food is consumed in the evening. Studies using early TRE — eating all food before 3pm or within a morning-to-early afternoon window — show benefits on insulin sensitivity, blood pressure, and oxidative stress that appear to go beyond what caloric restriction alone would predict.
When CR and IF are compared directly at equivalent caloric deficits, most animal studies show similar effects on longevity and metabolic health, suggesting calorie reduction itself — rather than timing or pattern — is the primary driver. However, this does not mean IF offers no advantages over simply eating less every day:
Autophagy induction: Extended fasting periods may induce more pronounced autophagy than equivalent caloric restriction spread across the day. Autophagy requires a specific metabolic state (low mTOR, high AMPK) that is more robustly activated during prolonged food absence than during chronic mild restriction.
Hormetic effects: Periodic fasting imposes a metabolic stress that may trigger adaptive responses (heat shock proteins, SIRT1 activation, ketone production) that chronic mild restriction does not.
Practicality and adherence: Many people find time restriction easier to maintain than calorie counting. The cognitive and social burden of tracking every calorie indefinitely is substantial; simply not eating before noon or after 8pm is a much simpler rule that many people can follow consistently.
Books that complement this dietary approach include Walter Longo's The Longevity Diet, which advocates for a specific form of periodic prolonged fasting (the fasting mimicking diet) combined with a plant-heavy everyday eating pattern. For intermittent fasting specifically, Mark Mattson's The Intermittent Fasting Revolution provides an accessible overview of the science. For a comprehensive evidence-based perspective on nutrition and longevity, Peter Attia's Outlive covers both approaches with appropriate nuance.
For those experimenting with extended fasting windows, electrolyte supplements that provide sodium, potassium, and magnesium during fasting periods help manage hunger, headaches, and energy levels, particularly during the adaptation phase.
One important nuance in the CR vs IF debate involves dietary protein. High protein intake is associated with greater muscle mass preservation and stronger anabolic signalling — desirable for maintaining functional capacity with age. But protein (specifically the amino acids leucine, methionine, and others) also activates mTOR and IGF-1, the very pathways that CR and IF work to reduce.
This creates a tension: optimise for muscle preservation (high protein) or optimise for longevity signalling (lower mTOR via protein restriction)? Current expert opinion generally favours maintaining adequate protein intake — particularly in older adults where sarcopenia risk is high — while achieving caloric modulation through reduction in processed carbohydrates and dietary fat rather than protein restriction. The growing evidence base for protein's role in preserving muscle, cognitive function, and metabolic health makes protein restriction a poor trade-off against its mTOR effects for most people.
The most defensible practical recommendations from current evidence:
1. Avoid chronic caloric excess: The evidence that chronically eating more than you need accelerates aging through mTOR overactivation, IGF-1 elevation, and adiposity is strong and consistent. Avoiding this is the most important dietary principle.
2. Consider time-restricted eating: Eating within an 8-10 hour window, ideally ending 2-3 hours before bedtime, has measurable metabolic benefits and improves circadian alignment without requiring calorie counting.
3. Periodic prolonged fasting: A 5-day fasting mimicking diet every 2-4 months, as studied by Walter Longo's group, has reasonably strong human data and provides autophagy induction benefits that daily TRE or mild CR may not match.
4. Maintain adequate protein: Target 1 gram per pound of ideal body weight to prevent lean mass loss during any caloric restriction strategy, particularly important in older adults.
The honest bottom line: both CR and IF extend lifespan in animals and improve health markers in humans, primarily through overlapping mechanisms involving mTOR inhibition, AMPK activation, and autophagy. Neither has been shown to dramatically extend human lifespan in randomised trials. The best intervention is the one you can actually sustain — and that integration into your real life, social context, and personal preferences should drive your choice between these evidence-based approaches.